The global preclinical Contract Research Organization (CRO) market, valued at $5.1 billion in 2024, is set to expand significantly with a projected CAGR of 9.2%, reaching $13.3 billion by 2033. The market's growth is primarily driven by increased investments in drug development and research. Toxicology testing is expected to be the highest revenue-generating segment, with a notable CAGR of...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian